Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

PIPERACILLIN

PIPERACILLIN SODIUM

Standard Dose
EQ 4GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PIPERACILLIN is listed in Drugs@FDA under application 065114 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 4GM BASE/VIAL Sponsor ISTITUTO BIO ITA SPA Submission history Latest submission status date: 2025-11-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIPERACILLIN is listed in Drugs@FDA under application 065114 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 4GM BASE/VIAL Sponsor ISTITUTO BIO ITA SPA Submission history Latest submission status date: 2025-11-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.